Global CAR-T Cell Therapies Market By Drug Type (Axicabtagene Cilolecucel, Tisagenlecleucel, Brezucabtagene Autoleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleucel), By Modality (Research and Commercialized), By Target Antigen (CD19, CD22, BCMA, and Others), By Indication, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033
Report Overview The Global CAR-T Cell Therapies Market size is expected to be worth around USD 10.2 Billion by 2033, from USD 2.8 Billion in 2023, growing at a CAGR of 13.8% during t...
